 |
市場調査レポート
商品コード
1455075
栄養補助食品・ワクチンの世界市場規模、シェア、成長分析、タイプ別、エンドユーザー別 - 産業予測、2024年～2031年Global Nutraceutical & Vaccine Market Size, Share, Growth Analysis, By Type(Nutraceutical and Vaccine), By End-User(Adult and Children) - Industry Forecast 2024-2031 |
||||||
| 栄養補助食品・ワクチンの世界市場規模、シェア、成長分析、タイプ別、エンドユーザー別 - 産業予測、2024年～2031年 |
|
出版日: 2024年03月18日
発行: SkyQuest
ページ情報: 英文 202 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の栄養補助食品・ワクチン市場規模は、2022年に530億1,000万米ドルと評価され、2023年の570億4,000万米ドルから2031年には1,024億9,000万米ドルに成長し、予測期間中（2024年～2031年）のCAGRは7.60%で成長する見通しです。
世界の栄養補助食品・ワクチン市場は、健康とウェルネスに対する意識の高まりに牽引され、近年著しい成長を遂げています。機能性食品、栄養補助食品、ハーブ製品で構成される栄養補助食品は、栄養の重要性に関する消費者の意識の高まりに後押しされ、その潜在的な健康上の利点と予防的資質により牽引力を増しています。同時に、ワクチン分野では、疾病予防への関心の高まり、ワクチン開発における技術進歩、世界の予防接種イニシアチブの拡大に後押しされ、需要が急増しています。194の加盟国が承認した世界保健機関（WHO）の「世界・ワクチン・アクション・プラン（Global Vaccine Action Plan）」からも明らかなように、世界各国政府はワクチンへの普遍的アクセスの確保に取り組んでいます。ワクチン接種目標に向けた進捗状況を測るための定期的な評価により、政府・非政府組織はこの分野の強化に重要な役割を果たしています。ユニセフとWHOが発表した包括的な「複数年計画」のようなイニシアチブは、公平なワクチン・アクセスを促進し、利害関係者の関与を強化することを目的としています。ジフテリア、百日咳、破傷風の3種混合ワクチンが世界的に数百万人の乳幼児に広く投与されていることに代表されるように、予防接種の普及率が高まっていることは、同市場の好調な軌道を裏付けています。一方、必須栄養素と抗酸化物質を豊富に含む栄養補助食品は、その予防健康効果がますます認識されるようになっており、世界中の消費者が自分の健康を優先し、ヘルスケアシステムの潜在的なコスト削減と健康な集団の育成を信じています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
栄養補助食品・ワクチンの世界市場：タイプ別
- 市場概要
- 栄養補助食品・ワクチン
栄養補助食品・ワクチンの世界市場：エンドユーザー別
- 市場概要
- 大人・子供
栄養補助食品・ワクチンの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Pfizer Inc.（US）
- Johnson & Johnson（US）
- Novartis International AG（Switzerland）
- Merck & Co., Inc.（US）
- GlaxoSmithKline plc（UK）
- Sanofi S.A.（France）
- AstraZeneca plc（UK）
- Abbott Laboratories（US）
- Eli Lilly and Company（US）
- Gilead Sciences, Inc.（US）
- Amgen Inc.（US）
- Bristol Myers Squibb（US）
- Moderna, Inc.（US）
- Roche Holding AG（Switzerland）
- Novo Nordisk A/S（Denmark）
- Takeda Pharmaceutical Company Limited（Japan）
- Bayer AG（Germany）
- Astellas Pharma Inc.（Japan）
- Daiichi Sankyo Company, Limited（Japan）
- AbbVie Inc.（US）
Global Nutraceutical & Vaccine Market size was valued at USD 53.01 billion in 2022 and is poised to grow from USD 57.04 billion in 2023 to USD 102.49 billion by 2031, growing at a CAGR of 7.60% during the forecast period (2024-2031).
The global nutraceutical and vaccine market has experienced remarkable growth recently, driven by increasing awareness of health and wellness benefits. Nutraceuticals, comprising functional foods, dietary supplements, and herbal products, are gaining traction due to their potential health advantages and preventive qualities, fueled by rising consumer consciousness regarding nutrition importance. Concurrently, the vaccine sector has seen a surge in demand, propelled by a heightened focus on disease prevention, technological advancements in vaccine development, and expanding global immunization initiatives. Governments worldwide are committed to ensuring universal access to vaccines, as evidenced by the World Health Organization's 'Global Vaccine Action Plan,' endorsed by 194 member states. With regular evaluations to gauge progress towards vaccination targets, governmental and non-governmental entities play vital roles in bolstering the sector. Initiatives like the comprehensive Multi-Year Plan, published by UNICEF and WHO, aim to promote equitable vaccine access and enhance stakeholder involvement. The growing immunization coverage, exemplified by the widespread administration of the Diphtheria, Pertussis, and Tetanus vaccine to millions of infants globally, underscores the market's flourishing trajectory. Meanwhile, nutraceuticals, enriched with essential nutrients and antioxidants, are increasingly recognized for their preventive health benefits, with consumers worldwide prioritizing their well-being, believing in the potential cost savings for healthcare systems and fostering healthier populations.
Top-down and bottom-up approaches were used to estimate and validate the size of the global nutraceutical & vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Nutraceutical & Vaccine Market Segmental Analysis
Global Nutraceutical & Vaccine market is segmented by type, platform, and region. Based on type, the market can be segmented into nutraceutical, and vaccine. Based on platform, the market is segmented into adult and children. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Nutraceutical & Vaccine Market
A key catalyst propelling the global nutraceutical and vaccine market forward is the escalating focus on preventative healthcare. As awareness regarding the significance of preserving holistic wellness and warding off diseases continues to rise, there's an increasing need for products that provide health advantages and bolster the immune system. Consumers are proactively pursuing nutraceuticals and vaccines as integral components of their healthcare regimen. This surge is driven by evolving lifestyles, aging demographics, and the inclination to curtail healthcare expenditures by averting illnesses rather than addressing them post-manifestation.
Restraints in the Global Nutraceutical & Vaccine Market
One significant impediment facing the global nutraceutical and vaccine market lies in the strict regulatory frameworks and approval procedures. The journey from development to commercialization of nutraceuticals and vaccines demands meticulous testing, extensive clinical trials, and adherence to regulatory standards to guarantee safety, effectiveness, and quality. These procedures, albeit essential, often prove time-intensive and financially burdensome, particularly for smaller enterprises operating with constrained resources. The stringent regulatory environment may further lead to product launch delays and escalated compliance expenditures, consequently obstructing market expansion and stifling innovation within the nutraceutical and vaccine industries.
Market Trends of the Global Nutraceutical & Vaccine Market
A significant market trend in the global nutraceutical and vaccine industry is the rising interest in personalized and targeted healthcare solutions. Consumers are now more inclined towards products that meet their unique health requirements and genetic predispositions. This trend is driven by technological advancements like genomics, personalized medicine, and data analytics, enabling customized approaches to nutrition and vaccination. Market participants are adapting to this shift by creating personalized nutraceuticals and vaccines, delivering bespoke formulations and treatment strategies to tackle individual health issues and enhance outcomes. This trend underscores the move towards precision healthcare, acknowledging the diverse health needs of individuals.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Nutraceutical & Vaccine Market by Type
- Market Overview
- Nutraceutical and Vaccine
Global Nutraceutical & Vaccine Market by End-User
- Market Overview
- Adult and Children
Global Nutraceutical & Vaccine Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gilead Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amgen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bristol Myers Squibb (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Moderna, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Daiichi Sankyo Company, Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
